Annual increase of 0.24 percentage points seen in children aged 5 to 17 years and of 0.33 percentage points for young adults age 18 to 25 years ...

Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

Findings seen in pilot study that combines measurements from a depth camera, a forceplate, and an interface board ...

Study findings support the monitoring and management of iron status in patients with early stages of chronic kidney disease (CKD).

(HealthDay News) — The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, according to a study published online in Frontiers in ...

Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

Investigators assessed frailty prevalence in a nationally representative US cohort and inpatient outcomes among kidney transplant recipients.

Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...

Up to 30% of acute kidney injury (AKI) survivors requiring dialysis and personalized care after discharge from the hospital.

Topline data were announced from a phase 3 trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.